Skip to main content
. 2023 Mar 20;9(1):e12377. doi: 10.1002/trc2.12377

FIGURE 4.

FIGURE 4

Observed ARIA‐E in OLE versus simulated using PK/PD model in lecanemab‐treated (any dose) subjects from the core study.